Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Global Business Reports
Global Business Reports
Activities:
Media
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
LUNA 3: Rilzabrutinib Phase III immune thrombocytopenia trial meets primary endpoint
Rilzabrutinib met both the primary endpoint of durable platelet response and various secondary endpoints in patients who were refractory to prior therapy
Memel Biotech and Therabest collaborate to develop exosome-based cell therapies
The partnership will aim to develop, manufacture and distribute novel exosome cell therapies in a range of therapeutic areas
Ipsen and Skyhawk Therapeutics partner to develop RNA-targeting drug candidates
The USD $1.8bn deal will support the development of novel RNA-modulating drugs using Skyhawk's proprietary technology
Upcoming event
Cleanroom Conference UK
22–23 May 2024 | Exhibition | Birmingham, UK
See all
Related Content
Media
Foreign investment and the development of local CDMOs will drive growth in Indonesian pharma market
CPhI Pharma Insights report predicts growth in OTC and prescription generic drugs
CPhI South East Asia is helping to boost the regional economy
Event showcases a holistic picture of region’s pharma industry and releases Indonesia Pharmaceuticals 2015 Report
You need to be a subscriber to read this article.
Click here
to find out more.
Media
Turkish healthcare system responds to new phase of growth
Rising prosperity is driving an expansion of the healthcare infrastructure in Turkey, allowing manufacturers to move away from traditional generics and into contract manufacturing and R&D as well as export markets
Subscribe now